Nodal signaling plays critical roles during embryonic development. The Nodal gene is not expressed in adult tissues but is frequently activated in cancer cells, contributing to progression toward malignancy. Although several regulatory elements of the Nodal gene have been identified, the epigenetic mechanisms by which Nodal expression is regulated over the long term remain unclear. We found a region exhibiting dynamic changes in DNA methylation at approximately −3.0 kb to −0.4 kb upstream from the transcriptional start site (TSS) that we termed the epigenetic regulatory element (ERE). The ERE was unmethylated in mouse embryonic stem cells (mESCs) but became increasingly methylated in differentiated cells and tissues, concomitant with the downregulation of Nodal mRNA expression. In vitro reporter assays identified an Oct3/4 binding motif within the ERE, indicating that the ERE is responsible for the activation of Nodal in mESCs. Furthermore, the ERE was a target of differentiation-associated Polycomb silencing, and the chromatin condensed when mESCs differentiated to embryoid bodies (EBs). Pharmacological inhibition of PRC2 led to the reactivation of Nodal expression in EBs and mouse embryonic fibroblasts (MEFs). The ERE was also targeted by PRC2 in normal human cells. In NODAL-expressing human cancer cells, accumulation of EZH2 and trimethylation of H3K27 at the ERE were diminished. In conclusion, Nodal is epigenetically controlled through the ERE in the mouse embryo and human cells.
Introduction
Nodal is a protein ligand that belongs to the transforming growth factor-β (TGF-β) superfamily (Schier, 2009; Shen, 2007; Shiratori and Hamada, 2006) , and Nodal is expressed in the early inner cell mass (ICM) at embryonic day 3.5 (E3.5) (Granier et al., 2011) . Nodal becomes undetectable by E9.5 and remains undetectable in almost all adult somatic tissues ( Fig. 1A) (Conlon et al., 1994; Su et al., 2004) . Recent studies discovered that Nodal is involved in modulating the heterogeneity of mESCs (Galvin et al., 2010; Galvin-Burgess et al., 2013) .
Nodal plays critical roles in tumor progression as well as early embryonic development. The Nodal gene is misexpressed in some types of cancer, especially in malignant cells (Lee et al., 2010; Postovit et al., 2008; Quail et al., 2012) . Several lines of evidence showed that inhibition of Nodal reduced the proliferation of malignant cancer cells (Lee et al., 2010; Quail et al., 2012; Strizzi et al., 2012) . Thus, the strict control of Nodal expression is important.
We previously found that the Polycomb group proteins play key roles in the epigenetic silencing of Nodal in medaka fish (Oryzias latipes). Polycomb repressive complex 2 (PRC2) catalyzes trimethylation of histone H3 lysine 27 (H3K27me3) at its target locus, thereby establishing long-term repression of the target gene (Simon and Kingston, 2009 ). Disruption of PRC2 causes aberrant expression of Nodal on the right side of the body in medaka fish, followed by left-right reversal of internal organs (Arai et al., 2010) , suggesting that Nodal is a target of epigenetic silencing and the mechanism is critical for normal embryonic development. However, the PRC2 target sequence found in medaka fish is not conserved in the mouse, and the epigenetic mechanism of Nodal silencing remains to be elucidated.
DNA methylation, histone modification and several nuclear proteins are involved in long-term gene regulation (Ikegami et al., 2009) . DNA methylation occurs most commonly at the cytosine residue of CpG dinucleotides and is a stable epigenetic mark for target repression that is heritable through mitosis (Bird, 2002; Shiota, 2004; Yagi et al., 2012) . Eukaryotic genomes contain a large number of tissue-dependent and differentially methylated regions (T-DMRs) that form a basis for cellular identity (Yagi et al., 2008) . Searching for the T-DMRs in a gene of interest is a means to detect the epigenetic control region by the higher-order structure of chromatin (Hattori et al., 2004 (Hattori et al., , 2007 .
In this study, we aimed to identify the T-DMR of Nodal in mice as an epigenetic regulatory element (ERE) and investigate if PRC2 is responsible for the epigenetic regulation.
Results

A T-DMR is located upstream of the mouse Nodal gene
Nodal gene expression was confirmed by RT-PCR in mouse embryonic stem cells (mESCs) (Fig. 1A and B) . The expression level observed in mESCs was maintained until day 2 of embryoid body (EB) formation and subsequently decreased on day 4. The expression of Oct3/4 and Nanog declined concomitantly with Nodal.
As shown in Fig. 1C , several enhancers have been reported to control cell type-dependent expression of Nodal (Adachi et al., 1999; Ben-Haim et al., 2006; Krebs et al., 2003) . FoxH1 binds to the asymmetric enhancer (ASE) to induce Nodal expression in the epiblast, visceral endoderm, and left lateral plate mesoderm (LPM) (Adachi et al., 1999) . The node-specific enhancer (NDE) is required for Nodal expression only in the node (Krebs et al., 2003) . A proximal epiblast enhancer (PEE), controlled by Wnt signaling, has also been identified (Ben-Haim et al., 2006) .
We analyzed the DNA methylation status of Nodal in mESCs, E9.5 whole embryos, and the heart of an adult mouse (Fig. 1D , E). The region from −3053 bp to −410 bp of the transcriptional start site (TSS) was almost completely unmethylated in mESCs, whereas it was~63% methylated in the adult heart, indicating that the T-DMR is located at the locus (−3053 bp~−410 bp of TSS) of the Nodal gene. This T-DMR was moderately methylated on E9.5 embryos (26%-27%). EBs of days 2 and day 4 revealed 10% and 26% methylation, respectively. Thus, the T-DMR at −3053 bp~−410 bp seems to be responsible for the silencing of Nodal, and as a result, we designated this region the epigenetic regulatory element (ERE) (Fig. 1D) . On the other hand, DNA methylation of ASE, PEE, and NDE did not change significantly among the cells and tissues examined (Fig. 1D, E) .
According to the ENCODE database (Bernstein et al., 2012) , the ERE (−3053 bp~−410 bp) contains a DNase hypersensitive site in mESCs (Fig. 1C) . The Oct3/4 binding motif ATGTAGAT (Matoba et al., 2006) was found −2208 bp upstream from the Nodal TSS, around the center of the hypersensitive site (Fig. 1C) . Importantly, this binding motif was conserved in rodents (mouse and rat) and in primates (human and chimpanzee) (Fig. 1F) . Published ChIP-seq data show that pluripotency-related transcription factors (Oct3/4, Nanog, Sox2), as well as components of mediator and cohesin (Med1, Med12, Nipbl, Smc1), are enriched around the hypersensitive site (Kagey et al., 2010) (Fig. 1C). 
2.2.
The ERE induces Nodal expression through the conserved Oct3/4 binding motif Luciferase reporter assays revealed that −2691 bp to +11 bp of the TSS exhibited transcriptional activity in mESCs, but not in MEFs ( Fig. 2A, B) . This activity was markedly reduced by deletion of −2691 bp to −2009 bp, the region including the Oct3/4 binding element, indicating that the region is critical for control of Nodal expression ( Fig. 2A, B) . shRNA-mediated knockdown of Nanog, Med12, or Oct3/4 induced suppression of the luciferase activity in mESCs (Fig. 2C, D) . Among them, knockdown of Oct3/4 caused severe reduction of the luciferase activity and expression of Nodal mRNA (Fig. 2C, D) . Therefore, the ERE is responsible for the expression of Nodal in mESCs. Furthermore, Nodal appears to be regulated by pluripotent factors through an Oct3/4 binding element located within the ERE. The ERE is a component of regulation of Nodal transcription through the Oct3/4 motif, which is surrounded by a DNase hypersensitive site in mESCs.
2.3.
Changes in the chromatin condensation of the ERE during EB formation with targeting by PRC2
DNase hypersensitive assay provides the chromatin condensation of the ERE of Nodal. Among the 6 regions (regions 1~5 in the ERE and ASE) (Figs. 1D, 3A) , region 2 (−2294 bp to −2117 bp), which contains the Oct3/4 binding site, is the most relaxed in mESCs (Fig. 3B) . In contrast, regions 1, 3, 4, 5, and ASE were relatively condensed in mESCs. Region 2 started to be condensed on day 2 of EB formation, and became more condensed in day 4 EBs (Fig. 3B) . Notably, the expression of Oct3/4 and Nanog remained high in day 2 EBs (Fig. 1B) , indicating that chromatin condensation preceded the diminution of Oct3/4 and Nanog participation. In addition, the other regions in the ERE also became more condensed along EB formation, suggesting that chromatin condensation occurs over the Oct3/4 binding area. Thus, region 2 contains a center of structural change in chromatin, and chromatin condensation is initiated by factors other than Oct3/4.
Considering the mechanism of chromatin condensation in the Nodal gene locus in medaka fish (Arai et al., 2010) , we hypothesized the participation of PRC2 in chromatin condensation at the ERE in the mouse. As expected, there was no accumulation of Ezh2 in the 5 regions in the ERE in undifferentiated mESCs (Fig. 3C ). In day 2 EBs, however, Ezh2 began to accumulate in the hyper-condensed regions (regions 1, 3, 4, and 5), while accumulation remained undetectable in region 2. Significant accumulation of Ezh2 was observed at all regions in day 4 EBs. With respect to the ASE, Ezh2 was detected in EBs; however, the level was lower than that observed in the ERE.
Furthermore, H3K27me3 was low in the ERE in mESCs and day 2 EBs, while the level was increased in day 4 EBs (Fig. 3D ). H3K27me3 in the ASE remained low during EB formation (Fig. 3D) . Therefore, the ERE may be the target of PRC2-mediated silencing through H3K27 trimethylation at day 4 of EB formation.
To further confirm the contribution of PRC2-mediated H3K27me3 in Nodal gene silencing, cells were treated with DZNep, an inhibitor of histone methyltransferase activity of PRC2 (Tan et al., 2007) , during the culture period for EB induction. The addition of DZNep from day 0 to day 4 increased Nodal expression, although EB formation was disrupted (Fig. 3E ). When cells were treated with DZNep for 24 h (day 5 to day 6), expression of Nodal in the differentiated EBs was increased (Fig. 3F ). Taken together, H3K27me3 catalyzed by PRC2 at the ERE is involved in Nodal gene silencing in EBs.
PRC2 represses Nodal through the ERE in MEFs
We examined the involvement of PRC2 in further differentiated cells, in which Nodal was completely silenced. Expression of Nodal was not detected in MEFs derived from E14.5 embryos (Fig. 4A ). Ezh2 and H3K27me3 were enriched at the ERE region 2 in MEFs (Fig. 4C, D) . We found that DZNep treatment induced expression of Nodal in MEFs and a decrease in the H3K27me3 EBs. Asterisk, P < 0.05 and double asterisk, P < 0.01. In (C), the accumulation of Ezh2 at ASE was significantly lower than at regions 1, 2, 3, or 5 (P < 0.05). In (D), the level of H3K27me3 at ASE was significantly lower than that at regions 1, 2, 3, or 5 (P < 0.01), or region 4 (P < 0.05). ND indicates no enrichment (values less than zero after subtraction of control IgG backgrounds). (E, F) RT-PCR analysis of mRNA expression in EBs treated with DZNep from day 0 to day 4 (E) and day 5 to day 6 (F). In (F), expression levels of Nodal were determined by RT-qPCR analyses. The data represent the average ± standard deviation of triplicate qPCR samples normalized by Actb. Double asterisk, P < 0.01 versus control cells. level at region 2 (Fig. 4A, D) . The methylation level of region 2 was low in both control (15%) and DZNep-treated MEFs (25%) (Fig. 4E) . Thus, PRC2-mediated H3K27me3 is involved in silencing of Nodal in MEFs. In this experiment, Oct3/4 expression, Nanog expression, and chromatin condensation were not substantially affected by DZNep treatment (Fig. 4A, B) . Thus, the Nodal gene is under the epigenetic control in mice.
PRC2 targets the human ERE in normal cells, but is evicted in cancer cells
We identified a NODAL-overexpressing human cancer cell line, SH-SY5Y, by using the Oncomine database (Rhodes et al., 2007) . The data suggest that SH-SY5Y expresses NODAL at a higher level than the MDA-MB-231 breast cancer cell line. Using RT-qPCR, we confirmed that the mRNA expression of NODAL in SH-SY5Y was quite weak compared to that in humaninduced pluripotent stem cells (hiPSCs), though higher than that in HeLa cells (Fig. 5B) . NODAL expression was not detected in MDA-MB-231 in our experiments (Fig. 5B) . As expected, NODAL was not expressed in normal human mammary luminal epithelial cells (MLECs) (Fig. 5B) , while OCT3/4 and NANOG mRNA were expressed in all of the cell types (Fig. 5C, D) .
We examined the Oct3/4 binding motif in the human NODAL gene. The Oct3/4 binding motif and the surrounding sequence are conserved between mouse and human (Fig. 5A) . The surrounding region of the OCT3/4 binding element is CpGfree. CpGs located downstream of the OCT3/4 site were heavily methylated in all types of cells examined. The region further downstream, as well as the region upstream, was weakly methylated in MDA-MB-231. However, these regions were heavily methylated in SH-SY5Y and HeLa cells, in which NODAL was expressed (Fig. 5G) . ChIP analysis showed that EZH2 and H3K27me3 were enriched at the ERE in MLECs, indicating that the ERE was targeted by PRC2 in normal human cells (Fig. 5E,  F) . The accumulation of EZH2 and the level of H3K27me3 at the ERE were also lower in cancer cell lines than in MLECs (Fig. 5E, F) . We searched the ENCODE database for information on H3K27me3 in human cancer cells (Bernstein et al., 2012) . We found that levels of H3K27me3 at the ERE are low in all cancer cell lines in the database, including A549, Caco2, Dnd41, HeLaS3, HepG2, and SK-N-SH. DZNep treatment increased the expression of NODAL in HeLa cells (Fig. 5B) . On the other hand, NODAL expression was not detected in DZNep-treated MDA-MB-231 and MLECs (Fig. 5B) . Thus, the human ERE is functional in the epigenetic control of NODAL.
Discussion
In this study, we found that Nodal/NODAL gene expression is epigenetically controlled through ERE region 2, which resides upstream of Nodal/NODAL conserved in the mouse and human genomes. Region 2 of the ERE contains the binding sites of Oct3/ 4, Med12, Med1, Nanog as well as PRC2; thus the region is an epigenetic regulatory center of Nodal under the control of DNA methylation, histone modification, and chromatin condensation.
The DNA methylation status of the ERE dynamically increased throughout development, whereas comparable changes did not occur in the authentic enhancer elements as ASE, PEE, and NDE. Over the course of EB formation, PRC2-mediated H3K27me3 accumulated throughout the ERE, but not ASE, coincidentally with chromatin condensation around the Oct3/4 binding site within the ERE and subsequent downregulation of the Nodal gene. Pharmacological inhibition of PRC2 resulted in the activation of Nodal expression in EBs. Therefore, PRC2 is responsible for the repression of Nodal through the ERE during early development. In MEFs, H3K27me3 remained in the ERE, as Nodal was completely silenced in these more differentiated cells. Nodal was reactivated by PRC2 inhibition in MEFs, indicating that PRC2 is also involved in the long-term silencing of the Nodal gene.
Previous study showed that the mediator creates DNA loops to connect enhancer regions to promoter regions (Kagey et al., 2010) . Pluripotent transcription factors (Oct3/4, Nanog, Sox2) and components of mediator and cohesin (Med1, Med12, Nipb1 and Smc1) are enriched in ERE region 2 in mESCs (Kagey et al., 2010) . We confirmed via reporter assay that Oct3/4, Nanog and Med12 promoted Nodal expression. Recently, the binding sites of Oct3/4, Nanog, Sox2, and Klf4 were identified and characterized (Papanayotou et al., 2014) . Therefore, region 2 is the regulatory region of Nodal by pluripotency-related transcription factors and mediator.
Site-specific relaxation of chromatin is critical for physical access to genes, thus the chromatin of active regulatory elements is generally in an open formation (Song et al., 2011) . However, the standing question is by what mechanism do the pluripotency-related transcription factors act in relation to chromatin status. Previous study demonstrated that the binding motif for OCT3/4 in human cells was active despite being buried in condensed chromatin, and could create de novo nucleosomedepleted regions if the DNA of the region was unmethylated (You et al., 2011) . Our study indicated that in addition to DNA methylation, PRC2 was another important regulator for inhibiting the function of Oct3/4. The chromatin of region 2 began to be condensed before Oct3/4 and Nanog levels declined during EB formation. Silencing of Nodal was disrupted by inhibition of PRC2 in EBs and MEFs, even though the expression of Oct3/4 and Nanog was not affected. It is likely that the chromatin primarily controls Oct3/4 and Nanog access to region 2. Meanwhile, it was reported that PRC2 and pluripotent factors, including OCT3/4, NANOG, and SOX2, co-occupy several repressed genes in hESCs (Lee et al., 2006) . Thus, it is also possible that Oct3/4 and Nanog remain bound to the ERE, but are functionally inhibited by PRC2. Notably, although Ezh2 was not detected, significant levels of H3K27me3 was observed at region 2 in day 2 EBs. At present, two experimentally identified isoforms and a number of computationally predicted splicing variants of Ezh2 have been found in the NCBI RefSeq database (Pruitt et al., 2014) . Such subtypes of Ezh2, which are not detectable with the antibody used in this study, may be responsible for trimethylation of H3K27 of region 2 at the early stages of EB formation. Alternatively, Ezh1, another H3K27me3 methyltransferase, may participate in regulation of region 2 (Shen et al., 2008) .
Silencing of NODAL is considered an important mechanism for the circumvention of cancer development and the corresponding therapeutic treatments (Lee et al., 2010; Postovit et al., 2008; Quail et al., 2012; Strizzi et al., 2012) . There are conserved regions between the mouse and human EREs, i.e., binding sites of Oct3/4, Nanog, and EZH2. In mouse and human normal cells (MEFs and MLECs), NODAL was silenced and EZH2 and H3K27me3 were enriched in the ERE. On the other hand, EZH2 and H3K27me3 in the ERE were diminished in 3 human cancer cell lines, and the expression of NODAL was detected in 2 of the 3 cell lines, suggesting epigenetic abnormality in these types of cancer cells that in turn cause the misexpression of NODAL. The mechanism by which PRC2 catalyzes H3K27me3 at the ERE is critical for NODAL gene silencing (summarized in Fig. 5H) .
Notably, although the accumulation of H3K27me3 at the ERE in MDA-MB-231 was almost identical to that observed in HeLa or SH-SY5Y, NODAL expression was not detected in MDA-MB-231. In addition to the ERE, epigenetic regulation of the promoter or other enhancers of NODAL may be involved in its expression in cancer cells. The other possibility is that, with low levels of H3K27me3, the ERE is poised for activation, but a complete set of transcriptional activators is required for full ERE function. Human OCT3/4 and NANOG act in concert with cofactors, including SOX2, KLF4, PRDM14, and p300 (Boyer et al., 2005; Chia et al., 2010) . Although both OCT3/4 and NANOG were expressed in MDA-MB-231 at a level similar to that observed in HeLa or SH-SY5Y, other transcription factors, or mediator components (as we demonstrated in mice), might be essential for activation of NODAL through ERE.
Expression of NODAL is restricted to the early developmental stage and is strictly repressed in normal adult tissues. Tissue-specific genes are often aberrantly activated in cancer cells, and such "out of context" expression could be a good marker for predicting the risk of metastasis (Rousseaux et al., 2013) . It has been shown that aberrant expression of NODAL may lead to malignant transformation (Lee et al., 2010; Postovit et al., 2008; Quail et al., 2012) . Because the expression of NODAL is epigenetically regulated through the ERE, the epigenetic state of the ERE may be an early marker for future metastasis.
In conclusion, we identified and characterized the ERE, a novel element responsible for epigenetic regulation of the Nodal gene. The ERE is involved in early murine development and in abnormal cellular dysfunctions found in cancer.
4.
Experimental procedures
Mice
Adult mice (C57BL/6N and BDF1) were purchased from Charles River Japan (Yokohama, Japan). Adult hearts were obtained from 13-week-old male C57BL/6N mice. E9.5 embryos were obtained from the mating of 6-week-old C57BL/6N males and females.
Cell culture
The MS12 mESC line derived from C57BL/6 mice was kindly provided by Dr. Hirofumi Suemori (Kawase et al., 1994) and cultured according to a standard protocol (Matise et al., 2000) . MS12 cells were maintained in an undifferentiated state by supplementing the medium with leukemia inhibitory factor (LIF) (Millipore, Billerica, MA). For the formation of EBs, MS12 cells were cultured in Low Cell Binding dishes (Thermo Scientific, Rockford, IL) in the absence of LIF. MEFs were derived from E14.5 C57BL/6N × BDF1 embryos and cultured as described (Matise et al., 2000) . HeLa cells were cultured in DMEM low-glucose medium with 10% fetal bovine serum (FBS) (Hyclone, Logan, UT). SH-SY5Y cells were cultured in DMEM/F12 medium supplemented with 10% FBS (Hyclone), 1% non-essential amino acids, 1 mM sodium pyruvate, 2 mM L-glutamine, and 0.15% sodium bicarbonate (Wako Pure Chemical, Osaka, Japan). MDA-MB-231 cells were cultured in DMEM high-glucose medium with 10% FBS (Hyclone) and 2 mM L-Glutamine. MLECs and customized medium (MEG-1) were purchased from Zen-Bio (Research Triangle Park, NC). The 253G1 human iPSC line (Nakagawa et al., 2008) was obtained from the RIKEN BioResource Center (Tsukuba, Japan). The hiPSCs were cocultured with SNF feeder cells in Primate ES Cell Medium (ReproCELL, Yokohama, Japan) supplemented with 5 ng/ml bFGF (Wako Pure Chemical).
Bisulfite sequencing
The bisulfite reaction was performed as described previously (Yagi et al., 2008) . PCR was performed on the bisulfitetreated genomic DNA with the following primers: −3153 to −3055, 5′-TTTTTAAGGGGAAGTATTATGAGTTGAT-3′ and 5′-CTTAACTACTAAACCATCTCACCAACC-3′; −2796 to −2305, 5′-AGTTTTTATTTAGTATTGAAGGTAT-3′ and 5′-ATTACCTAA TAAAATATATCCCCAA-3′; −2216 to −1654, 5′-TTTTAGATAAGA ATTTTTGGGGTGT-3′ and 5′-ATATACTAAATACTTTACCCACTTA-3′; −1505 to −901, 5′-AAAATTAGTTATGGAGGAGGAAAAT-3′ and 5′-ACCAAAACTACACAAAAAAACCCTA-3′; −836 to −430, 5′-AATTTATTTTGTAGATTAGGTTGAT-3′ and 5′-TAACTTCCT TACTCTACCTCTTCTA-3′; TSS (−310 to +199), 5′-GGTTGAAGT TAGTTAGGGTTT-3′ and 5′-CCAAACTTACAACCTACCTTA-3′; ASE (+697 to +1230), 5′-GTAGAAAGTTTAGAATTTAGGT-3′ and 5′-CATCACCATACAAACCTTCCAA-3′; PEE, 5′-TTTTTAGTTTGGTT GGGGTGAGAAT-3′ and 5′-CATTTCAAAACTACAAAAAACCCAA-3′; NDE, 5′-ATTTAGGGTTTAGAGTTGAATTAGT-3′ and 5′-TCTC CCTAACTCTTCTAAAAACATA-3′; and human ERE, 5′-ATTTTGG TGTTTGTTAAATTGTTGAT-3′ and 5′-CCAAAATTAACTAATC AAAATCACTA-3′. PCR products were cloned into the pGEM-T Easy vector (Promega, Madison, WI) and sequenced. The results were analyzed using the web-based tool QUMA (http://quma .cdb.riken.jp).
Luciferase assay
The genomic region from −2691 to +11 bp to the Nodal TSS was amplified with forward (5′-GCCGCCGGTACCATCACTCTG CACGGTCATG-3′) and reverse (5′-GCCGCCCCATGGTGGGCTG TTTGGACC-3′) primers (KpnI and NcoI restriction enzyme sites are underlined). To amplify a deleted fragment (−2008 to +11 bp), the following forward primer was used: (5′-GCCGCCGGTACC AGCCTCAATATCACAGAAAT-3′). These fragments were cloned into the firefly luciferase vector pGL3-Basic (Promega) via the KpnI and NcoI sites. MS12 cells or MEFs were plated in 24-well plates at 5 × 10 4 cells/well. On the following day, the cells were cotransfected with 0.8 µg of pGL3 and 0.01 µg of Renilla luciferase vector (pGL4.74 [hRluc/TK], Promega) using Lipofectamine 2000 (Life Technologies, Carlsbad, CA) according to the manufacturer's instructions. Twenty-four hours later, the cells were harvested and subjected to luciferase assays using the Dual Luciferase Reporter Assay System (Promega). To determine reporter activity, the expression of firefly luciferase from the pGL3 vector was normalized to the activity of Renilla luciferase.
shRNA-mediated gene knockdown
The puromycin-selectable pENTR-based shRNA expression vector was kindly provided by Drs. Makoto Miyagishi and Hideo Akashi. An internal ribosome entry site (IRES) and Venus sequence (Tanaka et al., 2008) were introduced downstream of the puromycin resistance gene to detect cells that had been successfully transfected. The shRNA target sequences were as follows: Nanog, 5′-GAACTATTCTTGCTTACAA-3′ (Loh et al., 2006) ; Oct3/4, 5′-GAAGGATGTGGTTCGAGTA-3′ (Loh et al., 2006) ; and Med12, 5′-GCCTTGTTCATGTTTCAGGAT-3′ (Kagey et al., 2010) . For expression analysis of knockdown cells, MS12 cells were seeded in 6-well plates at 2 × 10 5 cells/well. On the following day, cells were transfected with 4 µg of the shRNA expression vector using Lipofectamine 2000. Twenty-four hours later, transfected cells were selected by the addition of 1 µg/ml puromycin for 24 h. For the luciferase assay, cells were cotransfected with 0.6 µg of shRNA vector, 0.2 µg of pGL3 plasmid, and 0.005 µg of pGL4.74 (hRluc/TK), and then the cells were selected with puromycin.
RT-PCR
Total RNA was extracted with the RNeasy Mini Kit (QIAGEN, Hilden, Germany) and subjected to cDNA synthesis using Oligo (dT)20 primer and SuperScript III (Life Technologies), following the manufacturer's instructions. PCR was performed using BIOTAQ HS DNA Polymerase (Bioline, London, UK) under the following conditions: 95°C for 10 min, the indicated number of cycles at 95°C for 15 s, 58°C for 15 s, 72°C for 15 s, and finally 72°C for 2 min. The primer sequences and number of PCR cycles (unless otherwise specified) are as follows: Nanog: 5′-CTGTG TGCACTCAAGGACAGG-3′ and 5′-GCTTGCACTTCATCCTTTGGT-3′, 26 cycles; Med12: 5′-AGGAAGTGGAGGCTGTGGTTCTAC-3′ and 5′-AGGAACTCATGTCTGTCCAGCATTC-3′, 26 cycles; Oct3/ 4: 5′-CAGGCAGGAGCACGAGTGGAAAGC-3′ and 5′-CCAAAGAGAA CGCCCAGGGTGAGC-3′, 25 cycles; Nodal: 5′-ATCCTACCAAC CATGCCTACATC-3′ and 5′-ACAATCATGTCCTTGTGGTGTTC-3′, 26 cycles; and Actb: 5′-TTCTACAATGAGCTGCGTGTGG-3′ and 5′-ATGGCTGGGGTGTTGAAGGT-3′, 20 cycles. Amplified fragments were analyzed by agarose gel electrophoresis. Expression analysis in human cells was performed by real-time PCR with THUNDERBIRD SYBR qPCR Mix (Toyobo, Osaka, Japan) and the following primers: NODAL, 5′-CACTCTGCCATTATCCACATAC-3′ and 5′-CAAGCAGTACAACGCCTATC-3′; OCT3/4, 5′-GAAGGT ATTCAGCCAAACGA-3′ and 5′-AAATTCTCCAGGTTGCCTCT-3′; NANOG, 5′-CAGCCCCGATTCTTCCACCAGTCCC-3′ and 5′-CGGA AGATTCCCAGTCGGGTTCACC-3′; and ACTB, 5′-CCACCATGTAC CCTGGCATTG-3′ and 5′-TGCGCTCAGGAGGAGCAATG-3′.
4.7.
Comparative study
Sequences of the mouse ERE (NCBI37/mm9) and the orthologous genomic regions of rat (Baylor 3.4/rn4), human (NCBI36/hg18), and chimpanzee (CGSC 2.1/panTro2), were obtained from the UCSC genome browser (http://genome.ucsc .edu/) and aligned using CLUSTALW (http://www.genome.jp /tools/clustalw/). Dot plots were generated using the YASS program (Noé and Kucherov, 2005) with an E-value threshold set at 1 × 10 −8 .
Nuclease hypersensitivity assay
Assays were performed using the EpiQ Chromatin Analysis Kit (Bio-Rad, Hercules, CA) according to the manufacturer's instructions. Purified DNA was analyzed by real-time PCR with THUNDERBIRD SYBR qPCR Mix (Toyobo). The cycling conditions were as follows: 95°C for 1 min, followed by 40 cycles each at 95°C for 15 s and 60°C for 35 s. Primer sequences were as follows: region 1, 5′-AAGAAGCTTCTATCCAGTAC-3′ and 5′-CAGCAAGCATGACCGTGCAG-3′; region 2, 5′-TTACTGGGGAC ACATCCTAC-3′ and 5′-AAGGACGCTGTCTCCTGAAC-3′; region 3, 5′-GGGAGCTTAAGACTAGACTAC-3′ and 5′-CCTGTAGGAA CTGCTCTAAAC-3′; region 4, 5′-AACTAGTCATGGAGGAGGAAAAC-3′ and 5′-ACGCTGCATAAATGATTGAGTTC-3′; region 5, 5′-CCCCTTACCCTAAGCCTTAC-3′ and 5′-CCAGACCTGCTGAC TTTGTC-3′; ASE, 5′-CCACATCTTCTAATCCGGTCTG-3′ and 5′-ACCCTTCAAGAGAGGGTCAC-3′; and Gapdh, 5′-CAGCTCCCC TCCCCCTATCAGTTCG-3′ and 5′-ACCAGGGAGGGCTGCAGT CCGTATT-3′.
Chromatin immunoprecipitation (ChIP)
Mouse monoclonal antibody against H3K27me3 (MABI0323) was purchased from Wako Pure Chemical and rabbit monoclonal antibody against Ezh2 (D2C9) was from Cell Signaling Technology (Danvers, MA). Mouse IgG (ab18413, Abcam, Cambridge, MA) and rabbit IgG (ab27478, Abcam) served as negative controls for the anti-H3K27me3 and anti-Ezh2 antibodies, respectively. ChIP analyses were performed using the ChIP-IT Express Enzymatic Kit (Active Motif, Carlsbad, CA) according to the manufacturer's instructions, with slight modifications. Briefly, after the final wash, the magnetic beads and immunoprecipitated chromatin were incubated in chromatin direct elution buffer (10 mM Tris-HCl [pH 8.0], 5 mM EDTA, 300 mM NaCl, and 0.5% SDS) at 95°C for 15 min, and then incubated at 65°C for 4 h to reverse the crosslinking. After treatment with RNase A and proteinase K, DNA was purified using the Chromatin IP DNA Purification Kit (Active Motif). qPCR analysis was performed using the same method as described for the nuclease hypersensitivity assay. Additional primer sequences were as follows: Irx2, 5′-GCATCCCACTTCTACAGTCCTC-3′ and 5′-TAACACGGCCTGAAATCTTCTC-3′ (Bernstein et al., 2006) ; human ERE, 5′-GACCCAGACCTTCAGATTTAG-3′ and 5′-GAGATTGTGTAACTGCACTCTAG-3′; and human GAPDH, 5′-ACCTCCCATCGGGCCAATCTCAGTC-3′ and 5′-GGCTGACTGTC GAACAGGAGGAGCA-3′.
Drug treatment
DZNep was purchased from Cayman Chemical (Ann Arbor, MI) and dissolved in DMSO. Cells were treated with 2 µM DZNep or DMSO (negative control).
Statistics
Student's t-test was used to determine the statistical significance of the observed differences.
